Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
John Hubbard Insider Profile
4 Followers
John Hubbard, Director at Agile Therapeutics, holds 0.00 shares in Science 37 (Ticker: SNCE), holds 976.00 shares in Agile Therapeutics (Ticker: AGRX).
John Hubbard has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Roles
Director
Roles that John Hubbard holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by John Hubbard
John Hubbard's Trading History
Agile Therapeutics
Jun 09, 2023
Director
Uninformative Buy
―
$374.78
Science 37
Mar 12, 2024
―
Uninformative Sell
11.79K
$0.00
List of latest transactions for each holding click on a transaction to see John Hubbard's performance on stock
You May Also Like
John Hubbard insider profile FAQ
What is the percentage of profitable transactions made by John Hubbard?
The percentage of profitable transactions made by John Hubbard is ―.
What is the average return per transaction made by John Hubbard?
The average return per transaction made by John Hubbard is ―.
What stocks does John Hubbard hold?
John Hubbard holds: AGRX, SNCE stocks.
What was John Hubbard’s latest transaction?
John Hubbard latest transaction was an Uninformative Sell of $11.79K.
What was John Hubbard's most profitable transaction?
John Hubbard’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is John Hubbard's role in Agile Therapeutics?
John Hubbard's role in Agile Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.